Detailansicht

Wissensnetz

Person

Philipp Mandel

Arzt

Name	Philipp Mandel
Ort	Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	PD Dr. med. Dr. rer. nat.
Beruf	Arzt (charakteristischer Beruf)
Weitere Angaben	ehemals tätig an der Martini-Klinik des Universitätsklinikums Hamburg-Eppendorf; Funktionsoberarzt und Leiter der Prostatakarzinom-Spezialsprechstunde in der Klinik für Urologie des Universitätsklinikums Frankfurt am Main
Datensatztyp	Person
GND-Nummer	1177745747
Datensatz-ID	1177745747
Beteiligt an alle anzeigen Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortality Perioperative Complications and In-Hospital Mortality in Partial and Radical Nephrectomy Patients with Heart-Valve Replacement Metastatic Squamous Cell Carcinoma of the Urinary Bladder: Urgent Call for New Therapies Contemporary treatment patterns and oncological outcomes of metastatic hormone-sensitive prostate cancer and first- to sixth- line metastatic castration-resistant prostate cancer patients Impact of time to metastatic disease onset and extent of disease volume across metastatic hormone-sensitive and castration-resistant prostate cancer Organ-confined pT2 ISUP4/5 vs. nonorgan confined pT3/4 ISUP2 vs. ISUP3 prostate cancer: differences in biochemical recurrence-free survival after radical prostatectomy ASO Visual Abstract: In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urological Cancer Surgery In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urologic Cancer Surgery Comparison of peri- and intraoperative outcomes of open vs robotic-assisted partial nephrectomy for renal cell carcinoma: a propensity-matched analysis Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathology Epidemiology of Unconventional Histological Subtypes of Urethral Cancer Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis Differences in long-term continence rates between prostate cancer patients with extraprostatic vs. organ-confined disease undergoing robotic-assisted radical prostatectomy: an observational studys Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathology Individuelle Dosimetrie der Nieren bei der Therapie des metastasierten kastrationsresistenten Prostatakarzinoms mit 177Lu-Prostataspezifischem Membranantigen (177Lu-PSMA) mittels konventioneller nuklearmedizinischer Diagnostik Prädiktive Faktoren für das funktionelle Outcome der Prostataarterienembolisation bei Benignem Prostatasyndrom mit und ohne präinterventioneller Magnetresonanzangiographie The significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better? Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomy The Impact of Preoperative Double-J Stent on Perioperative Complications, Recurrence, and Quality of Life in Adult Patients Undergoing Pyeloplasty Concordance between preoperative mpMRI and pathological stage and its influence on nerve-sparing surgery in patients with high-risk prostate cancer Diagnosis of clinically significant prostate cancer diagnosis without histological proof in the prostate-specific membrane antigen era: the jury is still out Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups Effect of neoadjuvant chemotherapy on complications, in-hospital mortality, Length of stay and total hospital costs in bladder cancer patients undergoing radical cystectomy Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomy Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patients The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomy The significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better? Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer Urethral sphincter length but not prostatic apex shape in preoperative MRI is associated with mid-term continence rates after radical prostatectomy Thulium-Faserlaser: ein Uro-Laser für alles? Hematologic safety of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities Incidence rates and contemporary trends in primary urethral cancer Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomy Catheterization Does Not Improve Course of Disease in Female Patients with Acute Cystitis or Pyelonephritis: Retrospective Analysis of >300 In-Hospital Treated Patients Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients Correlation of MRI-lesion targeted biopsy vs. systematic biopsy gleason score with final pathologicalg gleason score after radical prostatectomy Correlation of urine loss after catheter removal and early continence in men undergoing radical prostatectomy Effect of chemotherapy on overall survival in contemporary metastatic prostate cancer patients Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomy Hematologic safety of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer Immunohistochemistry for prostate biopsy - impact on histological prostate cancer diagnoses and clinical decision making Impact of time to castration resistance on survival in metastatic hormone sensitive prostate cancer patients in the era of combination therapies Improvement in overall and cancer-specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patients Increased risk of postoperative in-hospital complications after radical prostatectomy in patients with prior organ transplant Increasing rates of NCCN high and very high-risk prostate cancer versus number of prostate biopsy cores Influence of biopsy gleason score on the risk of lymph node invasion in patients with intermediate-risk prostate cancer undergoing radical prostatectomy Influence of tumor burden on serum prostate-specific antigen in prostate cancer patients undergoing radical prostatectomy Inverse stage migration in radical prostatectomy - a sustaining phenomenon Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer Monoprophylaxis with cephalosporins for transrectal prostate biopsy after the fluoroquinolone-era: a multi-institutional comparison of severe infectious complications Multiparametric MRI may help to identify patients with prostate cancer in a contemporary cohort of patients with clinical bladder outlet obstruction scheduled for holmium laser enucleation of the prostate (HoLEP) Non-cancer mortality in elderly prostate cancer patients treated with combination of radical prostatectomy and external beam radiation therapy Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis Survival rates with external beam radiation therapy in newly diagnosed elderly metastatic prostate cancer patients The effect of lymph node dissection on cancer‐specific survival in salvage radical prostatectomy patients The effect of primary urological cancers on survival in men with secondary prostate cancer

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Philipp Mandel

Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortality

Perioperative Complications and In-Hospital Mortality in Partial and Radical Nephrectomy Patients with Heart-Valve Replacement

Metastatic Squamous Cell Carcinoma of the Urinary Bladder: Urgent Call for New Therapies

Contemporary treatment patterns and oncological outcomes of metastatic hormone-sensitive prostate cancer and first- to sixth- line metastatic castration-resistant prostate cancer patients

Impact of time to metastatic disease onset and extent of disease volume across metastatic hormone-sensitive and castration-resistant prostate cancer

Organ-confined pT2 ISUP4/5 vs. nonorgan confined pT3/4 ISUP2 vs. ISUP3 prostate cancer: differences in biochemical recurrence-free survival after radical prostatectomy

ASO Visual Abstract: In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urological Cancer Surgery

In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urologic Cancer Surgery

Comparison of peri- and intraoperative outcomes of open vs robotic-assisted partial nephrectomy for renal cell carcinoma: a propensity-matched analysis

Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathology

Epidemiology of Unconventional Histological Subtypes of Urethral Cancer

Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

Differences in long-term continence rates between prostate cancer patients with extraprostatic vs. organ-confined disease undergoing robotic-assisted radical prostatectomy: an observational studys

Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathology

Individuelle Dosimetrie der Nieren bei der Therapie des metastasierten kastrationsresistenten Prostatakarzinoms mit 177Lu-Prostataspezifischem Membranantigen (177Lu-PSMA) mittels konventioneller nuklearmedizinischer Diagnostik

Prädiktive Faktoren für das funktionelle Outcome der Prostataarterienembolisation bei Benignem Prostatasyndrom mit und ohne präinterventioneller Magnetresonanzangiographie

The significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better?

Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomy

The Impact of Preoperative Double-J Stent on Perioperative Complications, Recurrence, and Quality of Life in Adult Patients Undergoing Pyeloplasty

Concordance between preoperative mpMRI and pathological stage and its influence on nerve-sparing surgery in patients with high-risk prostate cancer

Diagnosis of clinically significant prostate cancer diagnosis without histological proof in the prostate-specific membrane antigen era: the jury is still out

Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups

Effect of neoadjuvant chemotherapy on complications, in-hospital mortality, Length of stay and total hospital costs in bladder cancer patients undergoing radical cystectomy

Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomy

Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patients

The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomy

The significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better?

Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer

Urethral sphincter length but not prostatic apex shape in preoperative MRI is associated with mid-term continence rates after radical prostatectomy

Thulium-Faserlaser: ein Uro-Laser für alles?

Hematologic safety of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer

Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities

Incidence rates and contemporary trends in primary urethral cancer

Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomy

Catheterization Does Not Improve Course of Disease in Female Patients with Acute Cystitis or Pyelonephritis: Retrospective Analysis of >300 In-Hospital Treated Patients

Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients

Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients

Correlation of MRI-lesion targeted biopsy vs. systematic biopsy gleason score with final pathologicalg gleason score after radical prostatectomy

Correlation of urine loss after catheter removal and early continence in men undergoing radical prostatectomy

Effect of chemotherapy on overall survival in contemporary metastatic prostate cancer patients

Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomy

Hematologic safety of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer

Immunohistochemistry for prostate biopsy - impact on histological prostate cancer diagnoses and clinical decision making

Impact of time to castration resistance on survival in metastatic hormone sensitive prostate cancer patients in the era of combination therapies

Improvement in overall and cancer-specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patients

Increased risk of postoperative in-hospital complications after radical prostatectomy in patients with prior organ transplant

Increasing rates of NCCN high and very high-risk prostate cancer versus number of prostate biopsy cores

Influence of biopsy gleason score on the risk of lymph node invasion in patients with intermediate-risk prostate cancer undergoing radical prostatectomy

Influence of tumor burden on serum prostate-specific antigen in prostate cancer patients undergoing radical prostatectomy

Inverse stage migration in radical prostatectomy - a sustaining phenomenon

Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer

Monoprophylaxis with cephalosporins for transrectal prostate biopsy after the fluoroquinolone-era: a multi-institutional comparison of severe infectious complications

Multiparametric MRI may help to identify patients with prostate cancer in a contemporary cohort of patients with clinical bladder outlet obstruction scheduled for holmium laser enucleation of the prostate (HoLEP)

Non-cancer mortality in elderly prostate cancer patients treated with combination of radical prostatectomy and external beam radiation therapy

Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

Survival rates with external beam radiation therapy in newly diagnosed elderly metastatic prostate cancer patients

The effect of lymph node dissection on cancer‐specific survival in salvage radical prostatectomy patients

The effect of primary urological cancers on survival in men with secondary prostate cancer